This evidence-based clinical guideline commissioned by NICE (National Institute for Clinical Excellence) presents guidance on the management of post-traumatic stress disorder (PTSD) in primary and secondary care. This volume includes all the evidence on which the guideline statements are based, and a detailed explanation of the methodology behind the guideline's preparation. Comprehensive information about PTSD (including prevalence, risk factors and diagnosis) and testimonies from PTSD sufferers are also provided. A data CD-ROM is included which presents: full details of studies included in the guideline and reasons for excluding studies, with reference list; a full list of guideline statements; all meta-analytical data presented as forest plots and detailed information about how to use and interpret forest plots.
Sprache
Verlagsort
Verlagsgruppe
The Royal College of Psychiatrists
Zielgruppe
Illustrationen
Maße
Höhe: 297 mm
Breite: 210 mm
Dicke: 11 mm
ISBN-13
978-1-904671-25-1 (9781904671251)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Guideline Development Group membership; Acknowledgements; List of abbreviations; 1. Introduction; 1.1. National guidelines; 1.2 - The national PTSD guideline; 2. Post-traumatic stress disorder; 2.1 - The disorder; 2.2 - Incidence and prevalence; 2.3 - Diagnosis and differential diagnosis; 2.4 - Aetiology of PTSD; 2.5 - Treatment and management of PTSD in the NHS; 2.6 - Primary care; 2.7 - Economic burden of PTSD; 3. Experiences of PTSD sufferers and carers; 3.1 - Personal testimonies from PTSD sufferers; 3.2 - Understanding PTSD from the sufferer's perspective; 3.3 - Summary of PTSD sufferer concerns; 3.4 - Carers' testimonies; 3.5 - Understanding the impact of PTSD on carers; 3.6 - Summary of carer needs; 3.7 - Clinical practice recommendations; 4. Methods used to develop this guideline; 4.1 - Overview; 4.2 - The Guideline Development Group; 4.3 - Clinical questions; 4.4 - Systematic clinical literature review; 4.5 - Health economics review strategies; 4.6 - Stakeholder contributions; 4.7 - Validation of this guideline; 5. Psychological treatment of PTSD in adults; 5.1 - Introduction; 5.2 - Definitions; 5.3 - Previous systematic reviews; 5.4 - Studies considered for review; 5.5 - Evidence statements; 5.6 - Clinical summary for psychological treatments; 5.7 - Recommendations for psychological treatments for chronic PTSD; 5.8 - Research recommendations; 6. Pharmacological and physical interventions for PTSD in adults; 6.1 - Introduction; 6.2 - Current clinical practice; 6.3 - Limitations of the literature: comparing RCTs of pharmacological and psychological treatment; 6.4 - Issues and topics covered by this review; 6.5 - Studies included; 6.6 - Study characteristics; 6.7 - General issues arising in the management of antidepressant medication; 6.8 - Repetitive transcranial magnetic stimulation; 6.9 - Clinical summary; 6.10 - Clinical practice recommendations; 6.11 - Research recommendations; 7. Early intervention for PTSD in adults.
